Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose albendazole for hookworm infection at Adet Primary Hospital
PACTR202010511829332Phase 4Completed
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of albendazole in hookworm infection. Primary endpoints: Cure rate and Egg reduction rate. Started Feb 2020; status: completed.
02
Drugs
albendazole
03
Conditions
hookworm infection
Beyond the preview
Go deeper on PACTR202010511829332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202010511829332.